SEED INNOVATIONS LIMITED — Board/Management Information 2021

Apr 12, 2021

National Storage Mechanism | Additional information

RNS Number : 1158V

FastForward Innovations Limited

12 April 2021

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

12 April 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

Specialist Appointed to Strengthen Investment Team

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that it has appointed Mr. Alfredo Pascual as Vice President of Investment Analysis effective 1 April 2021.

In this role, Alfredo's focus will be on sourcing and evaluating investment opportunities in the burgeoning European medical cannabis industry as well as supporting the growth of FastForward's portfolio companies in the sector.

Having worked in the cannabis space since the end of 2016, Alfredo is a well-known name in the sector across global markets.  Alfredo most recently worked as International Analyst at Marijuana Business Daily (MJBizDaily), the US-based business news and information resource, where he focussed on how cannabis markets and investments were evolving internationally.

Mr. Alfredo Pascual commented, "This is an important time to join the team at FastForward and I am keen to align my experience in the flourishing European medical cannabis sector with their position in the UK as the only quoted investment fund with a significant exposure to the space.

"After spending recent years analysing the complex European cannabis industry, I am excited to now work with FastForward to find and assess companies which are well positioned to capitalise on the opportunities being presented in the sector, and which are potential investment opportunities for FastForward."

Ed McDermott, Chief Executive Officer of FastForward, commented, "I am delighted to welcome Alfredo to our team; his experience and sector knowledge will be invaluable to FFWDs shareholders as our investment focus increasingly leans towards health, wellness and medical cannabis.  Alfredo is based in Germany which is home to the largest medical cannabis market in Europe. In this regard, we are extremely ambitious and with liquid assets valued at north of £12 million, we look forward to delivering more investment news shortly."

**ENDS**

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott Lance de Jersey	FastForward Innovations Ltd	Email: [email protected]
James Biddle Roland Cornish	Beaumont Cornish Limited, Nomad	Tel: +44 (0)20 7628 3396
Isabella Pierre Damon Heath	Shard Capital Partners LLP	Tel: (0)20 7186 9927
Catherine Leftley Megan Dennison	St Brides Partners Ltd, Financial PR	E: [email protected]

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEAXLAFLAFEEA